Search Results - Praveen, Kesavan Nair

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Abstract 1138: Rapid validation of a novel kinase target using a large scale genomic database and matched patient derived tumor models

    Abstract 1138: Rapid validation of a novel kinase target using a large scale genomic database and matched patient derived tumor models by Broudy, Thomas, Sanga, Sandeep, Ricono, Jill, Trikha, Mohit, Mirsaidi, Cyrus, Praveen, Kesavan Nair

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 2457: Ex vivo analysis of novel isoflavanoids (ME-143 and ME-334) in patient derived triple negative breast cancer tumors

    Abstract 2457: Ex vivo analysis of novel isoflavanoids (ME-143 and ME-334) in patient derived triple negative breast cancer tumors by Praveen, Kesavan Nair, Broudy, Thomas, Mirsaidi, Cyrus, Moreno, Ofir, Gold, Daniel

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 2794: Ex vivo chemoresponse assay using patient-derived tumor xenografts in combination with high content imaging platform as models for oncology drug development

    Abstract 2794: Ex vivo chemoresponse assay using patient-derived tumor xenografts in combination with high content imaging platform as models for oncology drug development by Garg, Mansi, Vo, Martin, Ricono, Jill, Broudy, Thomas, Mirsaidi, Cyrus, Praveen, Kesavan Nair

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 5270: Evaluation of Cell-able spheroid culture system for culturing patient derived primary tumor cells

    Abstract 5270: Evaluation of Cell-able spheroid culture system for culturing patient derived primary tumor cells by Praveen, Kesavan Nair, Streiner, Nicole, Vo, Martin, Anderes, Kenna, Yokota, Koichi, Ikeya, Takeshi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 881: Leveraging the molecular heterogeneity of patient-derived tumor samples to simulate clinical trial settings and model combination treatments

    Abstract 881: Leveraging the molecular heterogeneity of patient-derived tumor samples to simulate clinical trial settings and model combination treatments by Streiner, Nicole, Praveen, Kesavan Nair, Ruiz-Larroya, Tatiana, Vo, Martin, Murali, Bhavya, Hoffmaster, Steve, Broudy, Thomas, Mirsaidi, Cyrus, Anderes, Kenna

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 3611: Identifying gene expression markers of anticancer drug response using large scale genomic and drug response databases established from patient derived tumors

    Abstract 3611: Identifying gene expression markers of anticancer drug response using large scale genomic and drug response databases established from patient derived tumors by Broudy, Thomas, Nair, Kesavan Praveen, Livingston, Erica I., Hoffmaster, Steve, Vo, Martin, Sanga, Sandeep, Laurance, Megan, Mirsaidi, Cyrus, Anderes, Kenna

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Abstract B123: Novel high content molecular characterization and anticancer drug sensitivity profiling of more clinically relevant tumor models derived from patient primary tumors

    Abstract B123: Novel high content molecular characterization and anticancer drug sensitivity profiling of more clinically relevant tumor models derived from patient primary tumors by Nair, Kesavan Praveen, Streiner, Nicole, Hoffmaster, Steve, Vo, Martin, Broudy, Thomas, Mirsaidi, Cyrus, O'Connor, Patrick, Anderes, Kenna

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: